Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
moglabs.bio
Samples
Passed
Failed
Trust score updated: June 1, 2026 · 100% pass rate
Composite score based on 32 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 32 COAs attributed to this vendor. Last recomputed 2026-06-01.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 29, 2026 | KPV | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot KPV002 · Report V260429-20 007 |
| May 24, 2026 | TB-500 (Tβ4) | HPLC purity | PASS | 99.19% | Chromate | Lot TB002 · Report 35381 |
| May 24, 2026 | Semax | HPLC purity | PASS | 98.749% | Chromate | Lot SX002 · Report 35370 |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
| May 5, 2026 | Ipamorelin | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot IPA002 · Report V260406-1 013 |
| May 5, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot BT002 · Report V260406-1 011 |
| Apr 22, 2026 | Melanotan II | HPLC purity | PASS | 99.14% | Chromate | Lot MT202 · Report 34170 |
| Apr 22, 2026 | Selank | HPLC purity | PASS | 99.656% | Chromate | Lot SK002 · Report 34243 |
| Apr 22, 2026 | GLOW 70mg | HPLC purity | PASS | 99.776% | Chromate | Lot GLO002 · Report 34239 |
| Apr 22, 2026 | Melanotan I | HPLC purity | PASS | 99.609% | Chromate | Lot MT102 · Report 34167 |
| Apr 13, 2026 | HGH Frag. 176-191 | HPLC purity | PASS | 98.13% | Vanguard Laboratory | Lot HGF001 · Report V260406-1 010 |
| Apr 13, 2026 | GHRP-2 | HPLC purity | PASS | 98.05% | Vanguard Laboratory | Lot GH202 · Report V260410-23 008 |
| Mar 29, 2026 | hCG | Identity & safety panels | PASS | -- | Chromate | Lot HCG002 · Report 33589 |
| Mar 23, 2026 | Dapoxetine | Identity & safety panels | PASS | -- | Chromate | Lot DAP001 · Report 33376 |
| Mar 23, 2026 | Dihexa | HPLC purity | PASS | 99.457% | Chromate | Lot DIH001 · Report 33401 |
| Mar 19, 2026 | GHK-Cu | HPLC purity | PASS | 99.637% | Chromate | Lot GHK102 · Report 33562 |
| Mar 19, 2026 | GHK-Cu | HPLC purity | PASS | 99.966% | Chromate | Lot GHK002 · Report 33558 |
| Mar 18, 2026 | BPC-157 | HPLC purity | PASS | 98.353% | Chromate | Lot BPC002 · Report 33551 |
| Mar 4, 2026 | HCG | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot HCG002 · Report V260226-6 006 |
| Feb 16, 2026 | CJC-1295 DAC | HPLC purity | PASS | 99.842% | Janoshik Analytical | Report 109343 |
| Feb 16, 2026 | MOD GRF (1-29) + Ipamorelin | Identity & safety panels | PASS | -- | Janoshik Analytical | Report 109344 |
| Feb 13, 2026 | PEG MGF | HPLC purity | PASS | 99.223% | Janoshik Analytical | Report 109342 |
| Jan 23, 2026 | AOD-9604 | HPLC purity | PASS | 99.77% | Janoshik Analytical | Report 102679 |
| Jan 21, 2026 | Tesamorelin | HPLC purity | PASS | 99.151% | Janoshik Analytical | Report 101356 |
| Nov 12, 2025 | GHRP-6 | HPLC purity | PASS | 99.476% | Janoshik Analytical | Lot hg6001 · Report 88305 |
| Nov 12, 2025 | Ipamorelin | HPLC purity | PASS | 99.877% | Janoshik Analytical | Lot ipa001 · Report 88329 |
| Nov 12, 2025 | DSIP | HPLC purity | PASS | 99.116% | Janoshik Analytical | Lot dsp001 · Report 88318 |
| Nov 12, 2025 | GHRP-2 | HPLC purity | PASS | 99.283% | Janoshik Analytical | Lot hg2001 · Report 88302 |
| Nov 12, 2025 | — | Identity & safety panels | PASS | -- | Janoshik Analytical | Lot GBT001 · Report 88343 |
| Jun 4, 2026 | IGF-1 LR3 | HPLC purity | PASS | 98.64% | Vanguard Laboratory | Lot IGF102 · Report V260406-1 008 |
| Jun 4, 2026 | PT-141 | HPLC purity | PASS | 99.01% | Vanguard Laboratory | Lot PT402 · Report V260410-23 009 |
| Jun 4, 2026 | NAD+ | HPLC purity | PASS | 98.59% | Vanguard Laboratory | Lot NAD002 · Report V260226-6 001 |
| Jun 4, 2026 | Cagrilintide | HPLC purity | PASS | 99.06% | Vanguard Laboratory | Lot CAG002 · Report V260410-23 010 |
| Jun 4, 2026 | Retatrutide | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot RT1002 · Report V260226-6 004 |